Zhaodi Che

467 total citations · 1 hit paper
12 papers, 201 citations indexed

About

Zhaodi Che is a scholar working on Epidemiology, Pathology and Forensic Medicine and Hepatology. According to data from OpenAlex, Zhaodi Che has authored 12 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 3 papers in Pathology and Forensic Medicine and 3 papers in Hepatology. Recurrent topics in Zhaodi Che's work include Liver Disease Diagnosis and Treatment (7 papers), Alcohol Consumption and Health Effects (3 papers) and Liver Disease and Transplantation (2 papers). Zhaodi Che is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Alcohol Consumption and Health Effects (3 papers) and Liver Disease and Transplantation (2 papers). Zhaodi Che collaborates with scholars based in China, Hong Kong and Japan. Zhaodi Che's co-authors include Jia Xiao, Nai-Kei Wong, Lei Gao, Ziyuan Zhou, Siqi Li, Cunchuan Wang, Chengfang Xu, Linlin Xu, Yuan Yuan and Bin Wu and has published in prestigious journals such as Frontiers in Immunology, Trends in Molecular Medicine and Signal Transduction and Targeted Therapy.

In The Last Decade

Zhaodi Che

12 papers receiving 198 citations

Hit Papers

Liver diseases: epidemiology, causes, trends and predictions 2025 2026 2025 10 20 30

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhaodi Che China 6 87 47 45 23 19 12 201
Marina Serrano‐Maciá Spain 7 91 1.0× 27 0.6× 101 2.2× 23 1.0× 14 0.7× 11 200
Facheng Bai China 10 138 1.6× 101 2.1× 93 2.1× 15 0.7× 28 1.5× 14 268
Giovanna Valente Italy 9 136 1.6× 123 2.6× 52 1.2× 21 0.9× 30 1.6× 12 258
Xiaoli Ma China 7 134 1.5× 64 1.4× 39 0.9× 25 1.1× 27 1.4× 27 273
Khaled Thabet Egypt 6 133 1.5× 35 0.7× 68 1.5× 64 2.8× 21 1.1× 13 257
Raghu Ramanathan United States 11 121 1.4× 44 0.9× 101 2.2× 47 2.0× 22 1.2× 17 282
Liuying Chen China 10 140 1.6× 87 1.9× 127 2.8× 20 0.9× 54 2.8× 17 324
Esteban González Ballerga Argentina 6 87 1.0× 37 0.8× 14 0.3× 52 2.3× 27 1.4× 19 159
Nimy John United States 6 170 2.0× 55 1.2× 53 1.2× 75 3.3× 17 0.9× 13 212

Countries citing papers authored by Zhaodi Che

Since Specialization
Citations

This map shows the geographic impact of Zhaodi Che's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaodi Che with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaodi Che more than expected).

Fields of papers citing papers by Zhaodi Che

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaodi Che. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaodi Che. The network helps show where Zhaodi Che may publish in the future.

Co-authorship network of co-authors of Zhaodi Che

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaodi Che. A scholar is included among the top collaborators of Zhaodi Che based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaodi Che. Zhaodi Che is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Gan, Can, Yuan Yuan, Haiyuan Shen, et al.. (2025). Liver diseases: epidemiology, causes, trends and predictions. Signal Transduction and Targeted Therapy. 10(1). 33–33. 39 indexed citations breakdown →
2.
Che, Zhaodi, Mingxiang Cai, Xiaowu Dong, et al.. (2025). Angiotensinogen inhibition concurrently mitigates alcohol-associated hepatic and muscle injury. Metabolism. 169. 156275–156275. 1 indexed citations
3.
Zhou, Zheng-Qun, Zhaodi Che, Rui Zhang, et al.. (2024). Goji berry-derived phenylpropionyl phenylethylamine derivatives protect against ethanol-induced hepatic damage. Food Science and Human Wellness. 14(3). 9250074–9250074. 1 indexed citations
4.
Xiao, Jia, Fei Wang, Yuan Yuan, et al.. (2024). Epidemiology of liver diseases: global disease burden and forecasted research trends. Science China Life Sciences. 68(2). 541–557. 17 indexed citations
5.
Chen, Feng, Zhaodi Che, Yingxia Liu, et al.. (2023). Invigorating human MSCs for transplantation therapy via Nrf2/DKK1 co-stimulation in an acute-on-chronic liver failure mouse model. Gastroenterology report. 12. goae016–goae016. 1 indexed citations
6.
Yu, Qian, Chang Li, Qinghui Niu, et al.. (2023). Hepatic COX1 loss leads to impaired autophagic flux and exacerbates nonalcoholic steatohepatitis. Acta Pharmaceutica Sinica B. 13(6). 2628–2644. 7 indexed citations
7.
Che, Zhaodi, Ziyuan Zhou, Siqi Li, et al.. (2023). ROS/RNS as molecular signatures of chronic liver diseases. Trends in Molecular Medicine. 29(11). 951–967. 58 indexed citations
8.
Yuan, Yuan, et al.. (2023). Global trends in diabetic eye disease research from 2012 to 2021. Neural Regeneration Research. 19(10). 2310–2320. 5 indexed citations
9.
Xu, Linlin, Yuan Yuan, Zhaodi Che, et al.. (2022). The Hepatoprotective and Hepatotoxic Roles of Sex and Sex-Related Hormones. Frontiers in Immunology. 13. 939631–939631. 50 indexed citations
10.
Che, Zhaodi, Yali Song, Chengfang Xu, et al.. (2022). Melatonin alleviates alcoholic liver disease via EGFR–BRG1–TERT axis regulation. Acta Pharmaceutica Sinica B. 13(1). 100–112. 16 indexed citations
11.
Qu, Yibo, Zhaodi Che, Hua Wang, et al.. (2021). Sex bias in alcohol research: A 20-year comparative study. Frontiers in Neuroendocrinology. 63. 100939–100939. 4 indexed citations
12.
Che, Zhaodi, Zheng-Qun Zhou, & Jia Xiao. (2020). Mechanisms of wolfberry in the treatment of liver diseases. Chinese Science Bulletin (Chinese Version). 67(4-5). 351–363. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026